SARS-COV-2 δ variant drives the pandemic in India and Europe via two subvariants
Xiang-Jiao Yang
doi: https://doi.org/10.1101/2021.10.16.21265096
Xiang-Jiao Yang
1Rosalind & Morris Goodman Cancer Institute, McGill University, Montreal, Quebec H3A 1A3, Canada
2Department of Medicine, McGill University, Montreal, Quebec H3A 1A3, Canada
3Department of Biochemistry, McGill University, Montreal, Quebec H3A 1A3, Canada
4Department of Medicine, McGill University Health Center, Montreal, Quebec H4A 3J1, Canada
Article usage
Posted October 20, 2021.
SARS-COV-2 δ variant drives the pandemic in India and Europe via two subvariants
Xiang-Jiao Yang
medRxiv 2021.10.16.21265096; doi: https://doi.org/10.1101/2021.10.16.21265096
Subject Area
Subject Areas
- Addiction Medicine (398)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2911)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12693)
- Forensic Medicine (10)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4554)
- Geriatric Medicine (413)
- Health Economics (724)
- Health Informatics (2903)
- Health Policy (1067)
- Hematology (384)
- HIV/AIDS (920)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4321)
- Nursing (233)
- Nutrition (634)
- Oncology (2255)
- Ophthalmology (642)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1194)
- Primary Care Research (493)
- Public and Global Health (6903)
- Radiology and Imaging (1521)
- Respiratory Medicine (914)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)